Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?

Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):30896-30897. doi: 10.1073/pnas.2009961117. Epub 2020 Nov 17.

Yong Wang^{1

2}, Qing Mao^{3

4}, Xiangdong Zhou^{5

6}

¹ Department of Rheumatology, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing 400038, People's Republic of China.
² Department of Infection, Taikang Tongji COVID-19 Hospital, Wuhan 430000, People's Republic of China.
³ Department of Infection, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing 400038, People's Republic of China; xiangdongzhou@126.com qingmao@tmmu.edu.cn.
⁴ Department of Infection, Huoshenshan COVID-19 Hospital, Wuhan 430000, People's Republic of China.
⁵ Department of Infection, Taikang Tongji COVID-19 Hospital, Wuhan 430000, People's Republic of China; xiangdongzhou@126.com qingmao@tmmu.edu.cn.
⁶ Department of Respiratory and Critical Care Medicine, Southwest Hospital, Army Medical University (the Third Military Medical University), Chongqing 400038, People's Republic of China.

No abstract available

Publication types